17α-estradiol:: A brain-active estrogen?

The estrogen 17 beta-estradiol has profound effects on the brain throughout life, whereas 17 alpha-estradiol, the natural optical isomer, is generally considered less active because it binds less avidly to estrogen receptors. On the contrary, recent studies in the brain document that 17 alpha-estradiol elicits rapid and sustained activation of the MAPK/ERK and phosphatidylinositol 3-kinase-Akt signaling pathways; is neuroprotective, after an ischemic stroke and oxidative stress, and in transgenic mice with Alzheimer's disease; and influences spatial memory and hippocampal-dependent synaptic plasticity. The present study measured the endogenous content of 17 alpha-estradiol in the brain and further clarified its actions and kinetics. Here we report that: 1) endogenous levels of 17 alpha-estradiol and its precursor estrone are significantly elevated in the postnatal and adult mouse brain and adrenal gland of both sexes, as determined by liquid chromatography/ tandem mass spectrometry; 2) 17 alpha-estradiol and 17 beta-estradiol bind estrogen receptors with similar binding affinities; 3) 17 alpha-estradiol transactivates an estrogen-responsive reporter gene; and 4) unlike 17 beta-estradiol, 17 alpha-estradiol does not bind alpha-fetoprotein or SHBG, the estrogen-binding plasma proteins of the developing rodent and primate, respectively. 17 alpha-Estradiol was also found in the brains of gonadectomized or gonadectomized/adrenalectomized mice, supporting the hypothesis that 17 alpha-estradiol is locally synthesized in the brain. These findings challenge the view that 17 alpha-estradiol is without biological significance and suggest that 17 alpha-estradiol and its selective receptor, ER-X, are not part of a classical hormone/receptor endocrine system but of a system with important autocrine/paracrine functions in the developing and adult brain. 17 alpha-Estradiol may have enormous implications for hormone replacement strategies at the menopause and in the treatment of such neurodegenerative disorders as Alzheimer's disease and ischemic stroke.